Topic

Report Shows Encouraging Findings about C2M

by Ella Kidron

The newly released McKinsey China Consumer Special Issue 2020 further confirmed Gen Z’s (defined as post-1995 for the purpose of this piece) pursuit of “unique” products and services.

According to the findings, 51% of Gen Z consumers prefer brands that provide personalized products and 53% choose brands that provide customized services. This is good news for JD.com’s Consumer-to-Manufacturer (C2M) initiative, which helps brands and manufacturers bring customized products to market based on real consumer feedback and demand. Consumer preferences are becoming increasingly fragmented and specific, and having the capability to precisely understand and target consumers with the right products and services is key to winning their loyalty. This is especially true as consumers have more and more choices of platforms to shop on.

One area of custom products that draws attention from Gen Z is gaming phones. According to the China Industrial Research Institute, the number of mobile game players in China has reached 630 million. Screen size, battery capacity, heat dissipation capacity and more all affect the experience of mobile gamers. JD has worked with major brand manufacturers to create gaming phones through C2M. Red Magic, Nubia’s gaming phone brand and Black Shark’s 5G gaming phone are just a few examples of some of the products which have sold well on JD. In 2018, Black Shark launched the first gaming phone in China based on JD’s big data analysis. That same year, the first Red Magic gaming phone was also launched, with sales surpassing 10,000 in just 37 seconds.

The C2M model for product development not only improves customers’ experience, but also helps brands gain a deeper understanding of consumer trends and improves sales performance. The initiative also showcases JD’s supply chain strength. Over half of C2M phones sold on JD are gaming phones.

Customized services are another draw for Gen Z, which is less price sensitive as a generation than older generations and pays more attention to the holistic shopping experience. Providing services such as flexible broken screen insurance, full price trade in and more, go a long way in gaining loyalty from younger consumers.

 

 

(ella@jd.com)

 

 

 

JD Courier Awarded for Ensuring Medicine Reach Child in Need

by Hui Zhang

Qibo Kang, a JD courier based in Kunming city of Yunnan province, was awarded by the Ministry of Transport of the People’s Republic of China on Dec. 3 for his efforts in ensuring that essential medicine reached a child with leukemia during the pandemic.

On Feb. 4 JD Logistics received a request for help: A family with a child suffering from leukemia urgently needed medicine, and hoped that a JD courier might assist.

Qibo Kang

Qibo Kang

The family lives in Gejiu city, Honghe Hani and Yi Autonomous Prefecture, and usually travel to Kunming Children’s Hospital to pick up the medicine, but as a result of the pandemic traffic was temporarily suspended at the time, which made it impossible for them to retrieve the medicine from the hospital across different cities and regions.

Upon receiving the request, Kang immediately rushed to the hospital despite others’ concerns for safety. Kang underwent multiple disinfection processes at the hospital. He was able to get the medicine, only a few hours after receiving the call for help.

As roads between areas was temporarily closed during the pandemic, Yang Zhihui, the captain of Kang’s courier station, coordinated with other courier stations to assist the medicine transportation across different regions, passing hands until the medicine finally reached the family 16 hours later— a remarkably fast delivery time, considering the dire conditions.

When asked if he was afraid to go to the hospital, Kang said, “Yes, I was afraid, but I knew I had to go no matter what, because a sick child had to take medicine.”

“I’m also a father. When I hear things like this, I felt I should offer help,” said Kang.

 

(zhanghui36@jd.com)

 

JD Health’s Next Steps after IPO and COVID-19

by Vivian Yang

“The pandemic has changed many factors of the medical sector, pushed online medical consultation service to a new height, and ushered in a revolution in the medical industry,” commented Lijun Xin, CEO of JD Health at a press conference in Beijing following the company’s listing on Hong Kong Stock Exchange on Dec. 8, 2020.

Xin noted that at the beginning of the COVID-19, people did not have much choice but to go online for medical help. But over time, they realized the convenience and high-quality services and medical resources they can access through online platforms, and choose to stay with them even as the virus situation is now under control in China.

Lijun Xin, CEO of JD Health at the press conference  

Lijun Xin, CEO of JD Health at the press conference  

According to Xin, at present, daily online consultations remain at 100,000 on average on JD Health, making it the largest online medical consultation platform in China. In the meantime, JD Health’s online pharmacy platform offers over 150,000 types of pharmaceutical products to its customers, providing the most comprehensive range of medical supplies that people can  get on the Chinese market. And these medicine orders can be delivered at customers’ doorsteps within as fast as 30 minutes.

Supportive government policies, increasing cooperation with pharmaceutical enterprises, and active participation of individual doctors over the COIVD-19 period all fostered the rapid development of telemedicine, Xin said.

JD Health's full-time doctors at work 

JD Health’s full-time doctors at work 

Xin noted that JD Health will continue to focus on building up its supply chain capabilities to make healthcare services available whenever and wherever customers need them, and on increasing the accessibility of medical resources to let more people from very grassroots levels enjoy high-quality medical support.

“As long as we do our utmost to provide truly helpful healthcare services to our customers, revenue will come naturally,” said Xin.

With the money raised during this IPO, Xin said the team will continue to invest in pharmaceutical supply chain development and high potential enterprises that can supplement JD Health’s industry ecosystem, build greater healthcare platform that integrates more hospital resources and O2O services, and also prepare capital in case of another pandemic situation in the future.

In the next five years, Xin hopes telemedicine will serve as the largest patient triage platform in China, helping to guide more and more mild and chronic diseases to be taken care through telemedicine, and severe diseases and emergencies to be treated in offline hospitals. The whole process of diagnosis and treatment will be tracked online for closed-loop health management.

The press conference was attended by over 50 reporters either in-person in Beijing or virtually online from Hong Kong right after the ceremony to sound the gong, a traditional and standard Chinese way adapted by HKEX for celebration of new listing event. Register and watch the replay of the press conference here.

 

(vivian.yang@jd.com)

JD Health Experts Offer Free Consultations via Livestreaming for One Month

by Kelly Dawson

 

As JD Health’s listing on the Hong Kong Stock Exchange begins trading today, the company is continuing its efforts to serve consumers, with one month of free broadcasts by renowned doctors and medical experts.

The “JD Health Warm Winter Free Clinic Month” kicks off today, and will last until January 7th, featuring daily hour-long livestreaming sessions with experts including cardiovascular expert Hu Dayi; TCM master Xu Runsan; director of the department of general medicine at Peking University Health Science Center, Chi Chunhua; and others. Topics will include maternal and infant care, diabetes, TCM, heart and geriatric diseases, and more.

During each session, viewers can ask questions of the experts, who will answer them directly in the livestream. Additionally, JD Health will issue free consultation coupons and exclusive free consultation service packages during the broadcasts. Following each session, viewers can book telemedicine appointments with experts through the JD app and more.

The broadcast sessions and telemedicine services address an increasing demand for online medical services, which have skyrocketed as a result of the COVID-19 outbreak. Even as cases have slowed in China, telemedicine has gained headway as consumers realize the value of easy-access, fast online medical consultation.

 

(kellydawson@jd.com)

6618.HK: JD Health to Improve Consumer Service Through Omnichannel Solution

by Hui Zhang & Ling Cao

JD Health will expand cooperation with offline hospitals and medical institutions, and continue increasing investment into supply chain to improve consumer services through omnichannel solutions. Lijun Xin, CEO of JD Health, elaborated on these plans during an press conference in Beijing after JD Health was listed on the Hong Kong Stock Exchange (HKEX) on Dec. 8.

Lijun Xin, CEO of JD Health

Lijun Xin

“We saw investors are optimistic about China’s healthcare industry,” Xin said. “The biggest challenges we face are how to let more people know and experience our service, and how to combine offline medical institutions and hospitals with online medical resources.”

JD Health oversees retail and wholesale businesses covering pharmaceuticals, medical devices, and other healthcare products, both online and offline. The omnichannel solution is aimed at fulfilling consumers’ increasing healthcare consumption needs anytime and anywhere.

In addition to bringing high-quality and convenient health services to consumers, JD Health is also committed to facilitating the digitalization of its offline partners.

“Most offline pharmacies have not realized digitalization, and JD Health can leverage its capabilities to help them go digital,” Xin said. “At the same time, JD Health can promote online and offline integration and provide a comprehensive service including retail, healthcare management and supply chain.”

Leveraging its technology for small stores and supply chain advantages, JD has already partnered with more than 40 brands of offline pharmacy across China to provide data-driven recommendations about which products to stock, and help them better understand information about customer preferences.

JD Health listed on Hong Kong Stock Exchange (HKEX) on Dec. 8 with the ticker 6618.HK, and is set at a price of HK $70.58 per share.

 

(zhanghui36@jd.com, ling.cao@jd.com)

JD and China Southern Airlines Launch Ship-to-Home Luggage Service

by Yuchuan Wang

JD Logistics (JDL), JD.com’s logistics arm, has joined hands with China Southern Airlines to launch a “Ship-to-Home” luggage express delivery service for Chinese travelers.

Starting from December 6th, travelers to the destinations of Guangzhou Baiyun International Airport, Beijing Daxing International Airport, Shenzhen Bao’an International Airport and Wuhan Tianhe International Airport can book the service through China Southern Airlines’ app or the airline’s baggage inquiry desk, and JD Logistics will ship luggage directly to travelers’ home or designated addresses.

JD courier and China Southern Airlines’ staff packaging a traveler’s baggage

JD courier and China Southern Airlines’ staff packaging a traveler’s baggage

“The service allows a luggage-free travelling experience, so customers can save time instead of waiting at the baggage carousel,” said a representative from JD Express, the express delivery business of JD Logistics. “Travelers can also view the real-time location of their baggage through the China Southern Airlines’ mobile app.”

The service is priced starting from RMB 49 yuan (~US$ 7.5). Luggage will be delivered within the same day or next day, thanks to JD Logistics’ reliable express delivery network. To ensure peace of mind for travelers, the service also provides insurance for each item of luggage.

Earlier this year, JD Logistics announced its plan to speed up the efficiency of express delivery, providing 24-hour delivery service in over a thousand counties and tens of thousands of townships in China.

 

(yuchuan.wang@jd.com)

Cold Weather Drives Hot Products on JD

by Kelly Dawson

In the midst of a season China’s National Climate Center predicted to be the coldest winter in recent decades, Chinese consumers are spending big to stay warm. During a Super Brand Day for JD’s household necessities category, overall sales increased by 2.36 times when compared with average sales. Additionally, more than 1.18 million viewers tuned into a special livestream featuring Chinese craftsmen discussing the origin of home products.

Leading the sales spike were products including electric blankets, duvets and thermoses, which collectively saw an average daily sales increase of 300% compared with the previous month. Other popular products included blankets made of goose down or wool, and ultra-warm fabrics coated in antibacterial finishes, likely a reflection of increased vigilance toward germs as a result of COVID-19.

Chinese consumers also aimed to stay warm from the inside, with popular purchases including a Supor non-stick cooking set featuring a clip-on crisper and special pot for both frying and braising. Additionally, shoppers stayed hydrated with items like thermoses and tea sets.

During a year in which many people have stayed indoors more than usual, Chinese consumers also paid special attention to products designed to keep their homes tidy and easier for living, including the multi-functional large volume Xitianlong storage box.

China’s online and offline home appliance market totaled RMB 597.2 billion yuan in the first three quarters of 2020, of which JD took 26.97% market share, according to a recent report released by the China Center for Information Industry Development (CCID Group). Shopping behavior toward home appliance products are evolving, with Chinese consumers moving beyond their previous preference to only purchase new products when broken—now they are more likely to upgrade in the continued pursuit of a premium lifestyle and better products.

 

(Kellydawson@jd.com)

6618.HK: JD Health Celebrates Listing on HKEX

by Ella Kidron

JD Health listed on Hong Kong Stock Exchange (HKEX) on Dec. 8 at 9:30 am Beijing time with the ticker 6618.HK. The company held a celebration at JD.com headquarters in Beijing, virtually linked to the exchange in Hong Kong. Members of the JD.com and JD Health senior management and board, brand partners, financial and legal advisors, government representatives and employees all witnessed the ceremony.

According to HKEX’s announcement, JD Health is set at a price of HK $70.58 per share, and if the over-allotment option is not exercised, the net funds raised by the global offering will be about HK $26.5 billion.

In his remarks, Lijun Xin, CEO of JD Health, said: Led by Richard Liu, Chairman of JD.com, we started providing healthcare services in 2014 in order to solve industry pain points and create value for society. “2020 is not only an extraordinary year for everyone, but also a year in which JD Health creates social value and JD Health is recognized and understood by society.” Xin explained that in the face of COVID-19, JD Health immediately donated masks and medicines to Wuhan and joined forces with global supply chain partners to ensure the supply of epidemic prevention materials. In the span of three months, JD Health answered more than 10 million online consultation queries.

Members of the JD Health board, senior management of JD.com and JD Health all joined for the official sounding of the gong at opening bell.

Members of the JD Health board, senior management of JD.com and JD Health all joined for the official sounding of the gong at opening bell.

From left to right:  Ling Li, Director of the Health Development Research Center of Peking University and board member of JD Health; Xingyao Chen, Chairman of the Board and president of New Hope Group and board member of JD Health; and Yayun Li, CCO of JD.com and board member of JD Health; Rui Yu, CHO of JD.com; Demin Han, academician of the Chinese Academy of Engineering and president of the China International Exchange and Promotive Assocition for Medical and Health Care (CPAM); Lijun Xin, CEO of JD Health; Sandy Xu, CFO of JD.com and board member of JD Health; Dr. Jon Liao, CSO of JD.com; Xiangmei Chen, Kidney disease expert and academician of the Chinese Academy of Engineering and Dong Cao, CFO of JD Health

JD Health is dedicated to creating a complete and comprehensive “Internet + healthcare” ecosystem. The company provides a wide assortment of high-quality pharmaceutical and healthcare products that cater to all aspects of users’ diverse healthcare needs. Strong fulfillment capabilities enable timely and secure delivery of medical products while holistic healthcare services to satisfy users’ needs across all aspects of the healthcare products and services.

According to the company’s prospectus, JD Health’s total revenue for in the first three quarters of 2020 was RMB 13.2 billion yuan, an increase of 77.1% YOY. The company had 80 million users as of Sept. 30, 2020, nearly double that of 2017.

Xin said: “JD Health will take the listing as an opportunity to do its utmost to promote the medical and health industry towards higher quality, more efficient, more inclusive and more sustainable development to provide convenient accessible and affordable medical and health products and services, and to be people’s chief health manager.”

 

 

(ella@jd.com)